Jesus Moreno

Title: Innovations of Jesus Moreno in Pharmaceutical Chemistry

Introduction

Jesus Moreno is an accomplished inventor based in Dorchester Center, MA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of adenosine receptor antagonists. His work has the potential to impact the treatment of various diseases and conditions.

Latest Patents

One of Jesus Moreno's notable patents is titled "Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use." This patent encompasses a range of substituted amino triazolopyrimidine and amino triazolopyrazine compounds, along with their pharmaceutically acceptable salts. The invention details methods for preparing these compounds and their application as antagonists of A2a and/or A2b receptors, which are crucial in treating diseases mediated by these receptors.

Career Highlights

Jesus Moreno is currently associated with Merck Sharp & Dohme Corp., a leading pharmaceutical company. His role involves research and development in the field of drug discovery, where he applies his expertise to create innovative therapeutic solutions.

Collaborations

Throughout his career, Jesus has collaborated with esteemed colleagues, including Qiaolin Deng and Umar Faruk Mansoor. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Jesus Moreno's contributions to pharmaceutical chemistry, particularly through his patent on adenosine receptor antagonists, highlight his innovative spirit and dedication to advancing medical science. His work continues to pave the way for new therapeutic options in the treatment of various health conditions.